These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
984 related items for PubMed ID: 15590562
1. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O. IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562 [Abstract] [Full Text] [Related]
2. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression. Swellam M, El-Aal AA, AbuGabel KM. Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816 [Abstract] [Full Text] [Related]
3. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours. Le Frère-Belda MA, Cappellen D, Daher A, Gil-Diez-de-Medina S, Besse F, Abbou CC, Thiery JP, Zafrani ES, Chopin DK, Radvanyi F. Br J Cancer; 2001 Nov 16; 85(10):1515-21. PubMed ID: 11720438 [Abstract] [Full Text] [Related]
4. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F. Cancer; 2004 Jun 01; 100(11):2367-75. PubMed ID: 15160340 [Abstract] [Full Text] [Related]
5. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P. Hum Pathol; 2000 Jun 01; 31(6):751-60. PubMed ID: 10872671 [Abstract] [Full Text] [Related]
6. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A, Gaddipati JP, Moul JW, Srivastava S. J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401 [Abstract] [Full Text] [Related]
7. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM. Ann Surg Oncol; 2007 Dec 01; 14(12):3403-11. PubMed ID: 17882495 [Abstract] [Full Text] [Related]
8. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P, Schmidt M, Hu X, Wolff L. Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863 [Abstract] [Full Text] [Related]
9. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior. Garcia-España A, Salazar E, Sun TT, Wu XR, Pellicer A. Cancer Res; 2005 Feb 15; 65(4):1150-7. PubMed ID: 15734997 [Abstract] [Full Text] [Related]
10. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L, Eymin B, Brambilla E, Gazzeri S. Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784 [Abstract] [Full Text] [Related]
11. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Taniguchi N, Monden M. Hepatology; 1999 Jul 04; 30(1):90-9. PubMed ID: 10385644 [Abstract] [Full Text] [Related]
12. [Expression and significance of cell cycle regulators in gastric carcinoma]. Wu JF, Shao JC, Wang DB, Qin R, Zhang H. Ai Zheng; 2005 Feb 04; 24(2):175-9. PubMed ID: 15694028 [Abstract] [Full Text] [Related]
13. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. Shariat SF, Tokunaga H, Zhou J, Kim J, Ayala GE, Benedict WF, Lerner SP. J Clin Oncol; 2004 Mar 15; 22(6):1014-24. PubMed ID: 14981102 [Abstract] [Full Text] [Related]
14. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. Ishiguro A, Takahata T, Saito M, Yoshiya G, Tamura Y, Sasaki M, Munakata A. J Gastroenterol Hepatol; 2006 Aug 15; 21(8):1334-9. PubMed ID: 16872319 [Abstract] [Full Text] [Related]
15. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK. Br J Cancer; 2001 Jan 15; 84(2):270-5. PubMed ID: 11161387 [Abstract] [Full Text] [Related]
16. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R. Am J Clin Pathol; 2004 Sep 15; 122(3):444-52. PubMed ID: 15362377 [Abstract] [Full Text] [Related]
17. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lai S, El-Naggar AK. Lab Invest; 1999 Mar 15; 79(3):255-60. PubMed ID: 10092061 [Abstract] [Full Text] [Related]
18. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. Wong SC, Chan JK, Lee KC, Hsiao WL. J Pathol; 2001 May 15; 194(1):35-42. PubMed ID: 11329139 [Abstract] [Full Text] [Related]
19. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA. Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779 [Abstract] [Full Text] [Related]
20. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Arber N, Hibshoosh H, Yasui W, Neugut AI, Hibshoosh A, Yao Y, Sgambato A, Yamamoto H, Shapira I, Rosenman D, Fabian I, Weinstein IB, Tahara E, Holt PR. Cancer Epidemiol Biomarkers Prev; 1999 Dec 08; 8(12):1101-5. PubMed ID: 10613343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]